Search research articles
Contact Us
Filters
Showing results (131-140 of 575) with videos related to
Page
of 58
Sort By:
Nature Clinical Practice. Urology
|
February 14, 2006
Management of von Hippel-Lindau-associated kidney cancer
Robert L Grubb, Peter L Choyke, Peter A Pinto, et al.
The Journal of Urology
|
June 18, 2004
Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers
Darrel E Drachenberg, Othon J Mena, Peter L Choyke, et al.
Journal of Neurosurgery
|
January 16, 2007
Metastases to hemangioblastomas in von Hippel-Lindau disease
S Taylor Jarrell, Alexander O Vortmeyer, W Marston Linehan, et al.
The American Journal of Cardiology
|
September 1, 1986
Effects of bepridil on regional myocardial ischemia and comparison with verapamil
N Reifart, W Marston, M K Zierler, et al.
JAMA Dermatology
|
May 14, 2015
Comedonal and Cystic Fibrofolliculomas in Birt-Hogg-Dube Syndrome
Ohara Aivaz, Suzanne Berkman, Lindsay Middelton, et al.
The Journal of Urology
|
March 20, 2010
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes
Nick W Liu, Kiranpreet Khurana, Sunil Sudarshan, et al.
Neoplasia (New York, N.Y.)
|
September 7, 2012
Lack of a functional VHL gene product sensitizes renal cell carcinoma cells to the apoptotic effects of the protein synthesis inhibitor verrucarin A
Girma M Woldemichael, Thomas J Turbyville, James R Vasselli, et al.
Urologic Oncology
|
February 5, 2011
Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up
Gopal N Gupta, Ronald Boris, Paul Chung, et al.
Oncogene
|
February 13, 2002
Serial analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFalpha cytotoxicity
M Craig Caldwell, Colleen Hough, Stefanie Fürer, et al.
Journal of the American Academy of Dermatology
|
February 1, 2026
Facial tumor mapping distinguishes Birt-Hogg-Dubé syndrome from CYLD cutaneous syndrome
William Fostier, Kelli Karacki, Heidi H Kong, et al.
Page
of 58
Search research articles
Search
Showing results (131-140 of 575) with videos related to
Sort By:
Page
of 58
Nature Clinical Practice. Urology
|
February 14, 2006
Management of von Hippel-Lindau-associated kidney cancer
Robert L Grubb, Peter L Choyke, Peter A Pinto, et al.
The Journal of Urology
|
June 18, 2004
Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers
Darrel E Drachenberg, Othon J Mena, Peter L Choyke, et al.
Journal of Neurosurgery
|
January 16, 2007
Metastases to hemangioblastomas in von Hippel-Lindau disease
S Taylor Jarrell, Alexander O Vortmeyer, W Marston Linehan, et al.
The American Journal of Cardiology
|
September 1, 1986
Effects of bepridil on regional myocardial ischemia and comparison with verapamil
N Reifart, W Marston, M K Zierler, et al.
JAMA Dermatology
|
May 14, 2015
Comedonal and Cystic Fibrofolliculomas in Birt-Hogg-Dube Syndrome
Ohara Aivaz, Suzanne Berkman, Lindsay Middelton, et al.
The Journal of Urology
|
March 20, 2010
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes
Nick W Liu, Kiranpreet Khurana, Sunil Sudarshan, et al.
Neoplasia (New York, N.Y.)
|
September 7, 2012
Lack of a functional VHL gene product sensitizes renal cell carcinoma cells to the apoptotic effects of the protein synthesis inhibitor verrucarin A
Girma M Woldemichael, Thomas J Turbyville, James R Vasselli, et al.
Urologic Oncology
|
February 5, 2011
Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up
Gopal N Gupta, Ronald Boris, Paul Chung, et al.
Oncogene
|
February 13, 2002
Serial analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFalpha cytotoxicity
M Craig Caldwell, Colleen Hough, Stefanie Fürer, et al.
Journal of the American Academy of Dermatology
|
February 1, 2026
Facial tumor mapping distinguishes Birt-Hogg-Dubé syndrome from CYLD cutaneous syndrome
William Fostier, Kelli Karacki, Heidi H Kong, et al.
Page
of 58